Found: 3
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 45–52
Kachalov K.S., Solomina A.S., Rodina A.V., Kulakova A.V., Zhanataev A.K., Durnev A.D.
Introduction. Hyperglycemia inducers, the «classic» diabetogens streptozotocin and alloxan have a pronounced effect and are therefore limited suitable for modeling mild hyperglycemia in an experiment. Tyloxapol (Triton WR1339) was chosen as an alternative agen…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2022 · pp. 59–64
Lisitsyn A.A., Zhanataev A.K., Chaika Z.V., Sevostyanova E.M., Artamonova M.P., Chernukha I.M., Oganesyants L.A., Durnev A.D.
Introduction. An increase in DNA damage (genotoxicity) is characteristic of patients with diabetes mellitus. The main complications in diabetes are accompanied and/or initiated by DNA damage. Hence, the necessity to search for and study compounds with antigeno…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2017
Ostrovskaya R.U., Antipova T.A., Zolotov N.N., Nikolaev S.V., Logvinov I.O., Ozerova I.V., Gudasheva T.A., Seredenin S.B.
Introduction. Oxidative and nitrosative stresses are reported to be an important pathogenic factors of diabetes. Taking into account our previous findings that Noopept (N-phenyl-acetyl-L-prolyl-glycine ethyl ester) attenuates the hyperglycemia, decrease of inc…